TickerFacts.

Elanco Animal Health Inc (ELAN): Cost of Revenue

Annual figures by period end, from SEC filings.

$2.12B
Year ended 2025-12-31
$2.24B
Trailing 12 months to 2026-06-30
+3.5%
3-year compound annual growth
+4.9%
5-year compound annual growth
$2.13B2016-12-31: $1.41B2017-12-31: $1.49B2018-12-31: $1.57B2019-12-31: $1.47B2020-12-31: $1.67B2021-12-31: $2.13B2022-12-31: $1.91B2023-12-31: $1.93B2024-12-31: $2.00B2025-12-31: $2.12B$2.12B
2016-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$2.12B+5.9%2026-02-24, From 2025-01-01
2024-12-31$2.00B+3.7%2026-02-24, From 2024-01-01
2023-12-31$1.93B+0.9%2026-02-24, From 2023-01-01
2022-12-31$1.91B-10.3%2025-02-25, From 2022-01-01
2021-12-31$2.13B+27.9%2024-02-26, From 2021-01-01
2020-12-31$1.67B+13.4%2023-03-01, From 2020-01-01
2019-12-31$1.47B-6.6%2022-02-28, From 2019-01-01
2018-12-31$1.57B+5.3%2021-03-01, From 2018-01-01
2017-12-31$1.49B+6.0%2020-02-28, From 2017-01-01
2016-12-31$1.41Bn/a2019-02-20, From 2016-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Elanco Animal Health Inc (ELAN)2025-12-31$2.12B+5.9%
Perrigo Co PLC (PRGO)2025-12-31$2.76B-2.5%
Alnylam Pharmaceuticals, Inc. (ALNY)2025-12-31$677.17M+120.9%
Organon & Co. (OGN)2025-12-31$2.90B+8.0%
BioMarin Pharmaceutical Inc (BMRN)2025-12-31$717.44M+23.6%
United Therapeutics Corp (UTHR)2025-12-31$384.40M+24.1%
Amneal Pharmaceuticals, Inc. (AMRX)2025-12-31$1.91B+7.4%
Zoetis Inc. (ZTS)2025-12-31$2.67B-1.9%
Sarepta Therapeutics, Inc. (SRPT)2025-12-31$25.50Mn/a

Compare ELAN, PRGO, ALNY, OGN side by side · Screen every company in Pharmaceutical Preparations ↗